Search clinical trials for: Postmenopausal vasomotor symptoms

Total 244405 results

Hansoh BioMedical R&D Company

Not yet recruiting

A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women

Vasomotor Symptoms

China
Hansoh BioMedical R&D Company

Recruiting

Study of HS-10384 in Participants of Chinese Postmenopausal Women

Vasomotor Symptoms

China
Bonafide Health
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Recruiting

Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women

Vasomotor Symptoms | Postmenopausal Disorders

United States
Hanna Savolainen-Peltonen
University of Southern California

Recruiting

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

Cardiovascular Diseases | Atherosclerosis | Menopause | Estrogen Replacement Therapy

Finland
Northwestern University
University of Illinois at Chicago; Indiana University

Suspended

Stellate Ganglion Blockade in Post-Menopausal Women (R01)

Vasomotor Symptoms | Hot Flashes | Hot Flushes

United States
Estetra
ICON Clinical Research

Active, not recruiting

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Vasomotor Symptoms | Menopausal Symptoms

Spain, United States, Argentina, Lithuania, Poland, Italy, Hungary, United Kingdom, Romania, Czechia, Brazil, Canada, Russian Federation, Slovakia
MenoGeniX, Inc.
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women

Postmenopausal Symptoms

United States
Astellas Pharma Global Development, Inc.

Completed

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Hot Flashes | Menopause

United States
Daré Bioscience, Inc.

Completed

Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (DARE-HRT1)

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Wake Forest University Health Sciences

Completed

HIRREM Hot Flashes Study

Vasomotor Symptoms | Hot Flashes | Menopause

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Vasomotor Symptoms (VMS)

United States
Aylin Güneş

Completed

Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women (Vasomotor)

Quality of Life | Vasomotor Symptoms

Turkey
Acer Therapeutics Inc.

Completed

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Post-menopausal Vasomotor Symptoms

United States
Daré Bioscience, Inc.

Completed

A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
ASCEND Therapeutics
Solvay Pharmaceuticals

Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Postmenopausal Symptoms

United States
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Hot Flashes | Postmenopause

Mexico
Sojournix, Inc.

Terminated

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Hot Flashes

Belgium, Germany, Poland, United Kingdom
Bayer
Nerre Therapeutics Ltd.

Completed

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms (RELENT-1)

Post-menopausal Vasomotor Symptoms

United States
Astellas Pharma Singapore Pte. Ltd.

Completed

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Menopause

Korea, Republic of, China, Taiwan
Depomed

Completed

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women (Breeze3)

Hot Flashes

United States
Massachusetts General Hospital
National Institute on Aging (NIA); Brigham and Women's Hospital

Completed

Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women

Hot Flashes | Menopause | Vasomotor Disturbance

United States
Merck Sharp & Dohme LLC

Completed

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Vasomotor Symptoms | Menopause | Postmenopausal Symptoms
Radius Pharmaceuticals, Inc.

Terminated

Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Fervent Pharmaceuticals
Iqvia Pty Ltd

Completed

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

Hot Flashes

United States
Radius Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women

Hot Flashes

United States
Merck Sharp & Dohme LLC

Terminated

A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

Women | Moderate to Severe Vasomotor Symptoms in Postmenopausal
GlaxoSmithKline

Completed

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Menopausal and Female Climacteric States

United States, Australia, Argentina, Germany, United Kingdom, Spain, Italy, New Zealand, Sweden
Instituto Palacios
Ferrer Internacional S.A.

Completed

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms (OMEGASI)

Hot Flashes | Menopause

Spain
Monash University

Completed

Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms

Quality of Life | Menopausal Syndrome | Libido Disorder

Australia
University of Helsinki
Päivikki and Sakari Sohlberg Foundation, Finland; Finnish Medical Foundation; Emil Aaltonen Foundation

Completed

Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT) (SYMPTOM)

Cardiovascular Disease | Postmenopausal Vasomotor Symptoms

Finland
Noven Therapeutics

Completed

Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women (N30-005)

Postmenopausal Symptoms

United States
Noven Therapeutics

Completed

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) (N30-003)

Postmenopausal Symptoms

United States
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
EndoCeutics Inc.

Completed

Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

Vasomotor Symptoms | Hot Flushes

Canada
Duramed Research

Completed

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Nocturnal Vasomotor Symptoms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

United States
Depomed

Completed

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Hot Flashes

United States
Depomed

Completed

Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.

Hot Flashes

United States
Bionovo

Unknown

A Study of MF101 in Postmenopausal Women (HERBA)

Vasomotor Symptoms | Hot Flushes

United States
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton; Eli Lilly and Company; McMaster University

Unknown

Duloxetine for Major Depression in Peri-/Postmenopausal Women

Major Depressive Disorder

Canada
Laboratorios Casen-Fleet S.L.U.
Apices Soluciones S.L.; Asociacion Colaboracion Cochrane Iberoamericana

Unknown

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause (TRYSEM)

Postmenopausal Women With Moderate Vasomotor Symptoms

Spain
Depomed

Completed

Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women

Hot Flashes

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

Vasomotor Symptoms

Mexico
Upsher-Smith Laboratories

Completed

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Postmenopausal Symptoms
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women

Menopause | Vasomotor System

United States
Eli Lilly and Company

Completed

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Vasomotor Symptoms | Endometrial Safety

United States

3

Subscribe